Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

Gastroenterology

Volumn 116, Issue 4, 1999, Pages 804-812

  Michetti, P ^a   Kreiss, C ^a   Kotloff, K L ^a   Porta, N ^a   Blanco, J L ^a   Bachmann, D ^a   Herranz, M ^a   Saldinger, P F ^a   Corthesy Theulaz, I ^a   Losonsky, G ^a   Nichols, R ^a   Simon, J ^a   Stolte, M ^a   Ackerman, S ^a   Monath, T P ^a   Blum, A L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; UREASE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; IMMUNIZATION; IMMUNOGENICITY; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0033000163     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70063-6     Document Type: Article

References (34)

1. BJ Marshall JR Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311 1315
2. D Forman Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation BMJ 302 1991 1302 1307
3. AC Wotherspoon C Ortiz Hidalgo MR Falzon PG Isaacson Helicobacter pylori -associated gastritis and primary B-cell gastric lymphoma Lancet 338 1991 1175 1176
4. E Bayerdorffer A Neubauer B Rudolph C Thiede N Lehn S Eidt M Stolte Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection Lancet 345 1995 1591 1594
5. D Vaira A Ali' L Gatta C O'Morain Treatment of Helicobacter pylori Curr Opin Gastroenterol 14 1998 S71 S78
6. AF Goddard RPH Logan Antimicrobial resistance and Helicobacter pylori J Antimicrob Chemother 37 1996 639 643
7. SJ Czinn A Cai JG Nedrud Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization Vaccine 11 1993 637 642
8. MH Chen A Lee S Hazell PJ Hu YY Li Immunisation against gastric infection with Helicobacter species—first step in the prophylaxis of gastric cancer? Zbl Bakt Int J Med Microbiol 280 1993 155 165
9. P Michetti I Corthésy-Theulaz C Davin R Haas AC Vaney M Heitz J Bille JP Kraehenbuhl E Saraga AL Blum Immunization of BALB/c mice against Helicobacter felis infection with H. pylori urease Gastroenterology 107 1994 1002 1011
10. RL Ferrero JM Thiberge I Kansau N Wuscher M Huerre A Labigne The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice Proc Natl Acad Sci USA 92 1995 6499 6503
11. M Marchetti B Arico D Burroni N Figura R Rappuoli P Ghiara Development of a mouse model of Helicobacter pylori infection that mimics human disease Science 267 1995 1655 1658
12. I Corthésy-Theulaz N Porta M Glauser E Saraga AC Vaney R Haas JP Kraehenbuhl AL Blum P Michetti Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice Gastroenterology 109 1995 115 121
13. C Doidge I Gust A Lee F Buck S Hazell U Manne Therapeutic immunization against Helicobacter infection Lancet 343 1994 914 915
14. R Cuenca TG Blanchard SJ Czinn JG Nedrud TP Monath CK Lee RW Redline Therapeutic immunization against Helicobacter mustelaein naturally infected ferrets Gastroenterology 110 1996 1770 1775
15. JG Fox G Otto JC Murphy NS Taylor A Lee Gastric colonization of the ferret with Helicobacter species: natural and experimental infections Rev Infect Dis 13 suppl 8 1991 S671 S680
16. C Kreiss T Buclin M Cosma I Corthésy-Theulaz P Michetti Safety of oral immunization with recombinant urease in patients with Helicobacter pylori infection Lancet 347 1996 1630 1631
17. JD Clemens RA Finkelstein Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures Infect Immun 24 1979 760 769
18. M Stolte O Stadelmann B Bethke G Burkard Relationships between the degree of Helicobacter pylori colonization and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion Z Gastroenterol 33 1995 89 93
19. C Czerkinsky A-M Svennerholm M Quiding R Jonsson J Holmgren Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans Infect Immun 59 1991 996 1001
20. JD Clemens DA Sack JR Harris J Chakraborty PK Neogy B Stanton N Huda MU Khan BA Kay MR Khan Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli : results of a large-scale field trial J Infect Dis 158 1988 372 377
21. TH Ermak R Ding B Ekstein J Hill GA Myers CK Lee J Pappo HK Kleanthous TP Monath Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria Gastroenterology 113 1997 1118 1128
22. D Claeys E Saraga BC Rossier JP Kraehenbuhl Neonatal injection of native proton pump antigens induces autoimmune gastritis in mice Gastroenterology 113 1997 1136 1145
23. A Kantele Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine J Biotech 44 1996 217 224
24. M Quiding I Nordström A Kilander G Andersson LA Hanson J Holmgren C Czerkinsky Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory J Clin Invest 88 1991 143 148
25. JE Thomas S Austin A Dale P McClean M Harding WA Coward LT Weaver Protection by human milk IgA against Helicobacter pylori infection in infancy Lancet 342 1993 121
26. I Corthésy-Theulaz RL Ferrero Vaccines Curr Opin Gastroenterol 12 suppl 1 1997 41 44
27. K Hashigucci H Ogawa T Ishidate R Yamashita H Kamiya K Watanabe N Hattori T Sato Y Suzuki T Nagamine C Aizawa S Tamura T Kurata A Oya Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of holotoxin Vaccine 14 1996 113 119
28. EA Merritt TK Sixma KH Kalk BAM Vanzanten WGJ Hol Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT) Mol Microbiol 13 1994 745 753
29. N Lycke J Holmgren Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens Immunology 59 1986 301 308
30. RI Walker JD Clemens Use of the heat labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunization Vaccine Res 2 1993 1 10
31. G Douce C Turcotte I Cropley M Roberts M Pizza M Domenghini R Rappuoli G Dougan Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants Proc Natl Acad Sci USA 92 1995 1644 1648
32. BL Dickinson JD Clements Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity Infect Immun 63 1995 1617 1623
33. IE Corthésy-Theulaz S Hopkins D Bachmann PF Saldinger N Porta R Haas Y Zheng-Xin T Meyer H Bouzourene AL Blum JP Kraehenbuhl Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits Infect Immun 66 1998 581 586
34. H Kleanthous GA Myers KM Georgakopoulos TJ Tibbits JW Ingrassia HL Gray R Ding ZX Zhang W Lei R Nichols CK Lee TE Ermak TP Monath Rectal and intranasal immunization with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection Infect Immun 66 1998 2879 2886